Dr Mudasir Ahmad Lone

Multidisciplinary Nanotechnology Scientist, Nottingham University

United Kingdom

Mudasir is the MIT Solve Member. Being a multidisciplinary scientist and an ambitious individual, he aims at the development of novel solutions for global healthcare and diagnostic challenges alone and in association with other Solve's medicine and diagnostics related members. He intends to integrate his creative solutions with other members to initiate capable, innovative solutions to obdurate challenges in the material, medicinal, and healthcare world. He proposes equal standardization and globalization of healthcare services and innovation by introducing collaborations amongst Solvers to orchestrate the positive transformation. Moreover, Mudasir stands for the partnership and creation of challenging opportunities in the field of medicinal and healthcare technology for fostering technological advancement, innovation, research and development and employability globally. In addition to being an MIT Solver, Mudasir worked for advanced research projects such as (a) structural and nano-size characterization of survivin protein involved in many cancers, (b) development of nanoscale screening technology aimed to improve the microscale screening standard of protein-antibody based drugs in order to enhance their therapeutic efficiency and shelf life, and significance of single-molecule biomolecular force spectroscopic measurements and in understanding their influence on interaction between a drug moiety and the cellular molecules. He has also worked as a consultant at the UK based Innovation Enterprise (Olberon Medical Innovations Ltd), where he played role in medical devices designing, and technology consulting services to healthcare companies and medical professionals. Mudasir has been a recipient of several awards across Eurasia and holds first class Masters of Research in Single Molecule Nanotechnology and PhD in Biotherapeutic/Biopharmaceutical Nanotechnology, both from the UK’s number one and global top 10 School of Pharmacy at the University of Nottingham. He has received a high-quality advanced training in the field of Nanoscience and Nanotechnology from the Nottingham University’s Nanotechnology Center.
    Back
to Top